Invention Grant
US09453074B2 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
有权
通过树突状细胞脱唾液酸糖蛋白受体（DC-ASGPR）与抗原呈递细胞接触的药剂
- Patent Title: Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
- Patent Title (中): 通过树突状细胞脱唾液酸糖蛋白受体（DC-ASGPR）与抗原呈递细胞接触的药剂
-
Application No.: US14254206Application Date: 2014-04-16
-
Publication No.: US09453074B2Publication Date: 2016-09-27
- Inventor: Sangkon Oh , Dapeng Li
- Applicant: Baylor Research Institute
- Applicant Address: US TX Dallas
- Assignee: Baylor Research Institute
- Current Assignee: Baylor Research Institute
- Current Assignee Address: US TX Dallas
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; A01N63/00 ; C07K16/28 ; A61K47/48 ; A61K51/10 ; C07K14/005 ; C07K14/195 ; C07K14/37 ; C07K14/405 ; C07K14/435
Abstract:
The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Public/Granted literature
Information query
